Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trials

Files
Journal Article.pdf (863.85 KB)
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
WILEY-BLACKWELL
Abstract
Description
Keywords
Citation
WOS
URI
https://hdl.handle.net/10539/41704
Collections
Academic Wits Research Outputs (All submissions)